Single-Cell Omics Market

Single-Cell Omics Market Overview for 2024 to 2034

The Single-cell Omics Market is anticipated to be worth USD 3.6 billion in 2024. The market is expected to grow at a CAGR of 19.5% from 2024 to 2034. By the end of the forecast period, the market is predicted to hit USD 21.3 billion.

Single Cell Omics Market Size and Analysis

• Rising demand for research and development activities toward cancer therapy is expected to drive the demand for single-cell omics.
• Increasing cancer concerns worldwide are boosting market growth as single-cell omics act as an essential tool to decrease the complexity of tumors.
• Increasing activities regarding drug discoveries and personalized medicines, drive the market forward.
• Growing interest in biotechnology research is anticipated to fuel market demand in the coming years.
• As omics technology allows analysis of different types of applications such as brain science, tumor immunology, and pre-implantation which gaining popularity across the globe.
• Rising demand analysis of the difference between gene expressions in individual cells for the understanding of the intra-tumoral heterogeneity.
• Growing government funding for research and development for the life sciences.
• The need for precision medicine for targeted therapies is expected to drive the global demand for single-cell omics.

Attributes	Details
Single Cell Omics Market Size, 2024	USD 3.6 billion
Projected Market Size, 2034	USD 21.3 billion
Value-based CAGR (2024 to 2034)	19.5%

Opportunity Analysis in the Single-Cell Omics Market

• Rising chronic diseases and their need for therapies are expected to create lucrative opportunities for the forecast period.
• Increasing research for the genomic compositions.
• Single-cell genomics allows scientists and researchers to research the genomic composition of the individual cell.
• Growing usage of omics-based instruments for cancer therapy advancements is anticipated to create significant opportunities in the single-cell omics market.
• Investigation into transcriptomics and proteomics are gaining popularity among world scientists in the current period.
• Surge in innovation and research studies conducted by academic and research institutions presents greater opportunities in the single-cell omics market.

Restraints in the Single-Cell Omics Market

• Increasing complexity of data which is generated by the single-cell omics approach is expected to hamper the market growth during the forecast period.
• Availability of limited technology and limited sensitivity which shows false results is a major challenge for the industry.
• Lack of skilled professionals is anticipated to hinder the market expansion during the anticipated period. As need for well-educated and professional scientists has increased.
• The lack of standardization in integration and data analysis is a major concern for the market growth.
• The limited availability of funding for research and development across several regions.
• The challenges associated with the rare cell population investigation act as a major restraining factor in the industry.
• The stringent regulation of research and development by several governments is expected to hamper the market expansion in the projection period.

Category-wise Insights

In Material Type, the Single-Cell Genomics Segment Leads the Market

Attributes	Details
Top Product Type	Single-Cell Genomics
CAGR from 2024 to 2034	19.3%

• Increasing concerns regarding chronic diseases such as cancer and others are driving demand for the single-cell genomics segment
• Rising need for an alternative therapy option over traditional methods.
• Growing need for a cost-effective procedure for the single-cell analysis is anticipated to propel the single-cell genomics segment growth.
• Factors such as high resolution, and the need for the identification of rare cell populations make single-cell genomics a popular option among consumers.
• Surge in demand for precision medicine is leading to the increasing demand for single-cell genomics.
• The recent innovations in genomics technology such as droplet-based sequencing and microfluidics are expected to drive demand for single-cell genomics

The Oncology Segment Dominates the Market by Application

Attributes	Details
Top Application	Oncology
CAGR from 2024 to 2034	19.1%

• Increasing need for precise therapy and advanced diagnosis for chronic diseases.
• Oncology provides better and precise therapies and greater diagnostics which make it a popular choice among the patients.
• Advancements in technology as technology made it possible such as analyzing cell single with a greater accuracy and speed.
• Thus, technological advancement is expected to drive the demand for the oncology segment.
• Rising investment in public and private organizations for research purposes is anticipated to propel the segment in the forecast period.

Country-wise Insights

Countries	CAGR (2024 to 2034)
United States	19.8%
United Kingdom	20.7%
China	20.4%
Japan	21.3%
South Korea	22.0%

Rising Research and Development Activities in the United States

• The market for single-cell omics in the United States is witnessing steady growth over the years driven by several factors.
• The incidences related to cancer, cardiovascular diseases, and diabetes in the United States.
• For instance, according to the American Cancer Society, an estimated 1.9 million new cancer cases in the United States will be diagnosed in 2021, and 608,570 cancer deaths.
• Rising research and development activities in the United States are expected to drive the demand for single-cell omics.
• Technological advancement in the United States played a crucial role in the single-cell omics market.
• Increasing demand for personalized medicines in the United States. As single-cell omics allow researchers to identify specific genetic mutations which helps to develop personalized medicines.

Increasing Government Funding Toward Research and Development in the United Kingdom

• Rising focus on the drug discovery and drug development in the United Kingdom.
• Single-cell omics can identify new drug targets that are driving demand for the drug discovery process as single-cell analysis tools are used in the pharmaceutical and biotech industries in the United Kingdom.
• Increasing government funding toward research and development in the United Kingdom is driving the growth of the single-cell omics market in the United Kingdom.
• The demand for precision medicines in the United Kingdom is rapidly increasing in several years.
• Rising use of single-omics technology in agriculture and food research in the United Kingdom is expected to create lucrative opportunities in the single-cell omics market in the United Kingdom.

Increased Need for Effective and Precise Treatment in China

• The single-cell omics industry in China has shown steady growth over the years owing to several factors.
• The large and aging population is driving the demand for the single-cell omics market in China.
• As a population consumes more utilities such as medicines and others in China.
• Increased need for effective and precise treatment for patients in China. As having better healthcare infrastructure and facilities in China.
• Single-cell omics allow for the identification of genetic mutation and biomarkers which enables the development of precise and effective treatment options.

Rising Demand for Targeted Healthcare and Personalized Healthcare Solutions in Japan.

• Increasing number of the aging population in Japan.
• Growing prevalence of diseases such as diabetes, cancer, and other chronic diseases is anticipated to drive the demand for the single-cell omics market.
• As having advanced research centers and technologies, Japan is focusing on new drug development and drug discovery.
• The drug discovery leads the single-cell omics industry growth in Japan.
• Rising need for targeted healthcare and personalized healthcare solutions in Japan.
• Increasing single-cell sequencing in Japan for research. Sequencing is useful to study a wide range of biological processes and others.

Growing Use of Single-Cell Analysis Tools in South Korea.

• The market for single-cell omics in South Korea has been experiencing lucrative opportunities in recent years.
• The rising drug discoveries and drug development in South Korea have gained major market share in the country for the single-cell omics market.
• Growing use of single-cell analysis tools in South Korea.
• As scientists and researchers are using this tool for several research purposes which is driving demand for the single-cell omics market in South Korea.

Competitive Landscape

The market is highly competitive, with several key players vying for higher profit share. These companies offer a range of single-cell analysis tools and technologies, including single-cell sequencing platforms, microfluidic devices, and software for data analysis and interpretation.

As the demand for single cell analysis tools and technologies continues to grow, the market is expected to become even more competitive, with new players entering the market and established players expanding their offerings.

Recent Developments

• In 2023, Singular Genomics Systems, Inc. recently launched its Max read kits for single cell applications on the company's G4 sequencing platform. Singular Genomics Systems, Inc. is a California-based life sciences company that specializes in developing innovative sequencing technologies for genomic and transcriptomic analysis. Its recent launch of the Max read kits for single-cell applications on the company's G4 sequencing platform is expected to address the growing need for high-throughput single cell sequencing. The Max read kits offer a unique combination of high read accuracy and long read lengths, enabling researchers to analyze individual cells in greater detail than ever before.
• In 2023, Illumina Inc., a leading provider of DNA sequencing and array-based technologies, has recently announced the opening of a new office and Illumina Solutions Center in Bengaluru, India. The new facility is equipped with state-of-the-art technology and is expected to support the company's growing customer base in India and the broader Asia-Pacific region. The Illumina Solutions Center in Bengaluru will offer access to Illumina's portfolio of genomics solutions, including next-generation sequencing platforms, arrays, and software for data analysis and interpretation.

Key Market Players

• Mission Bio
• RareCyte, Inc.
• Cytena
• WaferGen Bio-systems
• Dolomite Bio
• Menarini Silicon Biosystems
• NanoCellect Biomedical
• Sphere Fluidics
• 1CellBio
• OnRamp Bioinformatics
• 10x Genomics
• Illumina
• Thermo Fisher Scientific
• Fluidigm Corporation
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Takara Bio, Inc.
• QIAGEN
• Norgen Biotek Corp.
• Fluxion Biosciences, Inc.

Key Coverage in the Single-Cell Omics Market Report

• Single-Cell Transcriptomics Market Report
• Single-Cell Genomics Market Analysis
• Single Cell Multiomics Market Statistics Assessment
• Single-Cell Metabolomics Market overview
• Single Cell Multiomics Kits Pricing Outlook

Key Market Segmentation

By Product Type:

• Single-cell Genomics
• Single-cell Transcriptomics
• Single-cell Proteomics
• Single-cell Metabolomics

By Application:

• Oncology
• Cell Biology
• Neurology
• Immunology
• Other Applications

By End User:

• Academic and Research Organizations
• Pharmaceutical & Biotechnology Companies
• Hospital and Diagnostic Laboratories
• Other End-Users

By Region:

• North America
• Latin America
• East Asia
• South Asia
• Europe
• Oceania
• MEA

Frequently Asked Questions

How Big is the Single Cell Omics Market in 2024?

The single cell omics market is estimated to be valued at USD 3.6 billion in 2024.

What is China’s Market Outlook?

The market in China is expected to progress at a CAGR of 20.4% through the forecast period.

Which Product Type Segment Contributes More to the Single Cell Omics Market?

The single cell genomics segment is expected to register a CAGR of 19.3% through 2034.

What is the United States Market Outlook?

The United States market is expected to register a CAGR of 19.8% from 2024 to 2034.

What is the Projected Market Value by 2034?

The market is set to reach a valuation of around USD 21.3 billion by the end of 2034.

What Was the Historical CAGR for the Market?

The demand for single-cell omics increased at a 23.9% CAGR from 2019 to 2023.